secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImageneBio, Inc. (IMA)
CIK:        0001835579
Form:       8-K
Filed at:   2025-07-11T23:59:59+00:00
Accession:  0001193125-25-157867
Event type: m_and_a
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ISS and Glass Lewis recommend Ikena stockholders vote FOR Inmagene merger
-------------------------------------------------------------------------

- Institutional Shareholder Services (ISS) and Glass Lewis recommend voting FOR share issuance related to merger with Inmagene.
- Ikena's Annual Meeting is July 15, 2025; record date was May 22, 2025.
- Inmagene's lead candidate is IMG-007, a nondepleting anti-OX40 mAb for immune & inflammatory diseases.
- CEO Mark Manfredi cited IMG-007's potential to build shareholder value in I&I space.
- Proxy includes seven proposals; all votes are important for merger approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835579/000119312525157867/0001193125-25-157867-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835579/000119312525157867/d826245d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-157867

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer